Request for Proposal (RFP) - Resilient Missile Warning Tracking (RMWT) Low Earth Orbit (LEO) Ground Entry Points (GEPs)
Department of the Air Force · Washington, DC
Why this score
28 days to respond, active buyer ($36.7B FY24–FY26).
Solicitation # RFI-NIAID-2026-001Updated Jun 11, 2026
This RFP closed on Jul 8, 2026.
Jul 8, 2026
Responses were due Jul 8, 2026, 5:00 PM EDT
Same NAICS group or Research & Scientific Services, nearby first, ranked by score.
Department of the Air Force · Washington, DC
Why this score
28 days to respond, active buyer ($36.7B FY24–FY26).
Department of the Air Force · Langley AFB, VA
Why this score
Active buyer ($36.7B FY24–FY26), 130 days to respond.
National Geospatial-Intelligence Agency (NGA)
Why this score
31 days to respond, active buyer ($98.2B FY24–FY26).
Department of the Air Force
Why this score
Active buyer ($36.7B FY24–FY26), well documented (5 files).
Department of the Air Force
Why this score
Active buyer ($36.7B FY24–FY26), well documented (7 files).
Department of the Air Force
Why this score
Active buyer ($36.7B FY24–FY26), well documented (5 files).
RFP Detector Scores are informational.How we score →
Summary by RFP Detector
National Institutes of Health (National Institutes of Health NIAID), part of the Department of Health and Human Services, posted a sources sought notice titled “Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID)” under solicitation number RFI-NIAID-2026-001. It was first posted on Jun 10, 2026 and has been updated once since. The response deadline was Jul 8, 2026, 5:00 PM EDT. It is classified under NAICS 541713 (Research and Development in Nanotechnology) and product/service code R702. No set-aside is listed. The listed point of contact is Miranda Adams.
Score at publication
Every RFP starts at 50. Each factor adds or subtracts points compared with a typical RFP; unknown data counts as neutral.
Frozen at publication: closed RFPs are not re-scored.
Starts at 50
No value published, and there isn't enough award history to estimate one. Scored as neutral.
Full and open competition.
2 other RFPs from National Institutes of Health on RFP Detector in the past 12 months; no award history found.
Sources sought (market research, not a bid): 28 days to respond (due Jul 8, 2026, 5:00 PM EDT).
Documents not listed, 2 named contacts with email and phone, 1,764-word description.
Posted today.
50 + contributions = 66 (B, Strong)
Informational, not advice to bid or not bid. Score version 1.0.0, evaluated Jun 10, 2026.
Eligibility · Full and open competition
Full and open competition means the notice states no set-aside: any responsible business can respond, subject to the requirements in the notice.
Not stated in a form we could extract. See the official solicitation for requirements, evaluation criteria and submission steps.
From the official notice
THIS IS A REQUEST FOR INFORMATION (RFI) ONLY In accordance with RFO 15.101(c), this RFI is issued solely for information and planning purposes. It does not constitute a solicitation for proposals, quotations, or abstracts, nor does it obligate the Government to award a contract or pay for any information provided. Responses will not be returned. No reimbursement will be made for costs associated with responding to this notice. 1. Background Research supported and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (HHS), strives to understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases that threaten millions of human lives. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all infectious agents, an essential component of U.S. efforts to ensure the health and safety of the American people. Through multiple grant- and contract-funded research programs, NIAID supports a broad range of clinical research, including single-site and multi-center trials spanning Phase 0-4 therapeutics and vaccines, new vaccine formulations, schedules, and modes of delivery; surveillance or natural history / cohort studies for pathogens of interest; evaluation of novel diagnostics; and clinical trials designed to find additional uses for already approved therapies for selected infectious diseases. The portfolio includes primarily domestic clinical sites, with the ability to support international studies. As part of clinical research portfolio, NIAID has regulatory obligations for clinical trials that include standardized deliverables, reporting, safety oversight, and monitoring. NIAID therefore requires resources to support its clinical research activities in compliance with regulatory requirements. One of those resources is a Statistical and Data Coordinating Center (SDCC) which provides centralized data management, statistical, and specimen tracking services essential to this clinical research portfolio. NIAID is exploring the re-competition of its Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID) contract. 2. Purpose The Government is issuing this RFI to: Facilitate early engagement with industry prior to release of a formal Request for Proposals (RFP), in accordance with RFO 15.101(c). Assess current market capabilities and vendor offerings relevant to SDCC services. Gather input on industry best practices to inform development of a future Statement of Work (SOW). Support fair and open competition in accordance with FAR 5.401. 3. Summary of Anticipated Scope and Targeted Feedback The anticipated SDCC contract encompasses the following broad functional areas. Respondents are encouraged to provide specific feedback on each area, including comments on feasibility, gaps, ambiguities, industry best practices, and any suggested refinements. 3.1 Overall Questions Targeted feedback requested: To what extent can or should Artificial Intelligence (AI) tools or platforms be incorporated into the SOW while maintaining confidentially of participant data? 3.2 Data Collection and Management The contractor will operate and maintain a state-of-the-art, 21 CFR Part 11-compliant clinical data system supporting data collection, automated data transfer, validation, storage, and submission to the FDA, from a large portfolio of domestic clinical sites, with the ability to support international studies. Targeted feedback requested: What commercial or proprietary platforms are best suited to support a portfolio of this scale and diversity while also meeting the standards of government-funded computer systems and Food and Drug Administration (FDA) regulatory submissions? What are their strengths and limitations in: an international setting; multi-site protocols; multi-protocol environments; and data collection methods from multiple sources, including electronic health records (EHR), electronic source, and paper source? How should the Statement of Work (SOW) address data system transition and continuity of operations at contract start-up to minimize disruption to ongoing studies? 3.3 Data Quality Assurance and Control The contractor shall provide and maintain a quality control system for monitoring the accuracy, completeness, and timeliness of the data, by study sites at each stage of a study, beginning with study initiation/participant enrollment and proceeding to the generation of final data sets. The system shall provide for verification of 100 percent of study data for audit readiness. Targeted feedback requested: What contractor involvement with development of data standards (i.e., via CDISC working groups and committees) should the SOW require to ensure innovation and continuous improvement in how data are collected? As CDISC and other standards continue to evolve, what mechanisms should the SOW require to ensure ongoing compliance without cost or schedule impact to the Government? 3.4 Protocol and Other Study-Related Materials The contractor shall provide services in the preparation, writing, review, revision, and distribution of protocol-related documents and materials (i.e., Manual of Procedures (MOP)) in collaboration with the study team and in support of implementation of the clinical protocol. Targeted feedback requested: What are industry standard timelines for development of clinical protocols and other study related materials, and what should the SOW require for their delivery schedule? What are industry standard timelines for the development of study data system(s), what best practices are recommended to facilitate rapid development of the data system, and what should the SOW require for the delivery schedule? 3.5 Communication, Collaboration, and Reporting The Contractor shall coordinate and collaborate with NIAID and other NIAID Clinical Research Infrastructure contractors and grant recipients to facilitate study implementation and assess study progress. The Contractor shall operate and maintain a web-based resource to share clinical research information and study materials with the NIAID, the study team, and participating study sites. Targeted feedback requested: What should the SOW require to ensure productive collaborations with multiple other contractors and grant recipients? What are industry standards for resources and platforms that can be used to share clinical research information at fixed costs to the Government? 3.6 Statistical Design and Analysis The Contractor shall provide expertise, advice, and assistance in the development of statistical designs of clinical concepts, statistical analysis plans, and in preparation of interim and final analyses for clinical research activities. Targeted feedback requested: What emerging statistical methodologies (e.g., adaptive trial designs, Bayesian approaches) should the SOW explicitly accommodate, and how should the Government structure tasking to access these capabilities efficiently? What should the SOW require for approaches or platforms for statistical analysis that encompass: standard clinical trial analysis, broad range of –Omics datasets, and generation of publication-ready tables and figures. 3.7 Clinical Site Training and Technical Assistance The Contractor shall train clinical site personnel on data systems and procedures, maintain a 24/7 help desk accessible from domestic and international locations, and assess site capabilities for studies not using SDCC systems. Targeted feedback requested: What are the most significant challenges in supporting clinical sites with respect to data system access, connectivity, and training, and how should the SOW account for them? 3.8 Electronic Specimen Tracking The Contractor shall provide and maintain an electronic specimen tracking system, for use by the SDCC, study sites, laboratories, and NIAID, to track study specimens in real time. Targeted feedback requested: Are there commercially available specimen tracking platforms that integrate natively with clinical data management systems, and should the SOW require such integration or permit modular solutions? 3.9 Data Storage The contractor shall maintain a secure and validated data storage system for clinical research and clinical trial data and analyses from current and future trials. Targeted feedback requested: What should the SOW include as requirements for data storage that allow for occasional data access for analysis while limiting cost to the Government? What should the SOW require for the maintenance of data from completed studies, such that results and performance metrics can be readily accessed from across all studies? 3.10 Data Sharing The contractor shall distribute, transfer, and/or share data and metadata to NIH and NIAID-designated repositories following completion of the clinical trial while ensuring data are appropriately and commensurately de-identified. Targeted feedback requested: What should the SOW require for methods and procedures to reliably de-identify clinical trial data? 3.11 Project Management The contractor shall provide for the overall management, integration and coordination of all contract activities, including the management and coordination of activities carried out under subcontracts if applicable Targeted feedback requested: What are critical elements of program and project management necessary to operate a resource to provide centralized data management and statistical services essential to support a wide variety of clinical research activities across multiple infectious disease programs involving domestic and international sites? 4. Requested Vendor Information In addition to SOW feedback above, respondents are asked to provide: Organizational Overview: Company name, address, UEI number, applicable NAICS code(s), and business size designation. Relevant Experience: Summary of prior or current experience managing SDCC or comparable data coordinating center functions, including scale (number of studies/sites) and therapeutic areas supported. Technical Capabilities: Description of systems, infrastructure, and personnel available to support the functional areas described above. International Experience: Demonstrated capability to support clinical trials at sites outside the United States. Teaming and Subcontracting: Whether your organization anticipates teaming agreements, or subcontracting, and in what functional areas. 5. Submission Instructions Responses should be limited to ten (10) pages or fewer, excluding cover page and organizational information. Submissions must be in PDF format and sent electronically to: Point of Contact: Miranda Adams, Contracting Officer Email: miranda.adams@nih.gov Responses are due no later than July 8, 2026, at 5:00 p.m. EDT. Telephone responses will not be accepted. The Government reserves the right to use any non-proprietary information received for acquisition planning purposes. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). All submissions become Government property and will not be returned. Disclaimer This RFI is issued solely for information and planning purposes to facilitate the acquisition planning process. It does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future, nor does it restrict the Government as to the ultimate acquisition approach. This notice does NOT obligate the Government to award a contract or otherwise pay for the information provided in response. Further, NIAID is not seeking proposals through this RFI and will not accept unsolicited proposals. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation. Any contract that might be awarded based on information received or derived from this RFI will be the outcome of a competitive process. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback with respect to any information submitted. Potential respondents should continue to monitor (see the official solicitation) for any follow-on solicitation or additional information related to this requirement.
No documents are listed for this notice.
Miranda Adams
PrimaryJonathan Bryan
Points of contact as published on the notice.
Sources Sought posted
Sources Sought posted
Responses were due
71 open RFPs from this issuer and its offices.
National Institutes of Health · Bethesda, MD
Why this score
Posted 8 days ago, active issuer (94 RFPs); but only less than a day left.
National Institutes of Health · Durham, NC
Why this score
Active buyer ($218M FY24–FY26), new this week; but only 2 days left.
National Institutes of Health · Maryland
Why this score
Not openly competed. Notice signals a sole-source or brand-name intent. The largest recipient took 11% of these dollars in FY24–FY26, and spending is spread across many vendors.
National Institutes of Health · Bethesda, MD
Why this score
Full and open, new this week; but small typical award (~$50K).
National Institutes of Health · Bethesda, MD
Why this score
New this week, full and open; but small typical award (~$52K).
National Institutes of Health
Why this score
Full and open, active buyer ($113M FY24–FY26); but small typical award (~$50K).
RFP Detector Scores are informational.How we score →
Official federal notice. Updated Jun 11, 2026.
Official solicitation:Sign in free to open the official solicitation
RFP Detector is an independent service and is not affiliated with any government agency. Scores are informational.
RFP Detector is not affiliated with the organization that issued this RFP. Always rely on the official notice and confirm every date and requirement with the issuer.